ORCHPHARMA — Orchid Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹49.30bn
- IN₹51.52bn
- IN₹12.32bn
Annual cashflow statement for Orchid Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19.5 | 463 | 890 | 995 | 104 |
| Depreciation | |||||
| Non-Cash Items | -503 | -34.1 | 109 | -53.2 | -12.7 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 577 | -794 | -72.1 | -1,095 | 732 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 925 | 183 | 1,260 | 192 | 1,256 |
| Capital Expenditures | -144 | -849 | -648 | -1,501 | -3,896 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1,273 | 537 | -2,472 | 1,232 | 1,127 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1,129 | -312 | -3,120 | -269 | -2,769 |
| Financing Cash Flow Items | -320 | -322 | -164 | -31.1 | -101 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2,168 | 312 | 1,670 | 252 | 1,371 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -114 | 183 | -190 | 175 | -141 |